Key result
Complement depletion reduces experimental aortic aneurysm expansion by ~66 percentage points.
Why the study?
Does complement activation via the alternative pathway and generation of C3a and C5a mediate neutrophil recruitment and aneurysm formation in elastase-induced abdominal aortic aneurysm?
Does complement activation via the alternative pathway and generation of C3a and C5a mediate neutrophil recruitment and aneurysm formation in elastase-induced abdominal aortic aneurysm?
Answers are grounded in this paper and cite their sources.
This preclinical study demonstrates that alternative pathway complement activation and both C3a and C5a anaphylatoxins drive neutrophil recruitment and aneurysm formation in experimental AAA, identifying dual C3a/C5a complement inhibition as a potential therapeutic target for human AAA.
BACKGROUND: We previously established that neutrophils play a critical role in the development of experimental abdominal aortic aneurysm (AAA). The signal that initiates the influx of neutrophils to the aortic wall, however, remains unknown. In this study, we tested the hypothesis that complement participates in the development of AAA by providing the necessary chemotactic signal that recruits neutrophils to the aortic wall. METHODS AND RESULTS: Using an elastase-induced model of AAA, we showed that pretreatment of C57BL/6 mice with cobra venom factor, which depleted serum of complement activity, protected mice from AAA development. Whereas control mice exhibited a mean aortic diameter of 156+/-2% on day 14 after elastase perfusion, mice treated with cobra venom factor exhibited a mean aortic diameter of 90+/-4% (P<0.001). Examination of mice deficient in factor B further indicated that the alternative pathway of complement played a major role in this process (mean aortic diameter of 105+/-4% in factor B-deficient mice, P<0.001 compared with controls). Activation of the alternative pathway led to generation of the anaphylatoxins C3a and C5a, which recruited neutrophils to the aortic wall. Moreover, antagonism of both C3a and C5a activity was required to block AAA, which suggests that each can independently promote the aneurysmal phenotype. In addition, we demonstrated that complement alternative-pathway involvement was not restricted to this experimental model but was also evident in human AAAs. CONCLUSIONS: The identification of involvement of the complement system in the pathophysiology of AAA provides a new target for therapeutic intervention in this common disease.
No takes yet. Share an insight, caveat, or question.
Pagano et al. (2009) studied Elastase-induced abdominal aortic aneurysm (AAA). Complement depletion (cobra venom factor) or alternative pathway/complement factor deficiency (fB-/-, C3-/-, C5-/-, C4-/-) and C5a receptor antagonist (C5aRA) vs. Untreated wild-type control mice or control peptide (C5RC) treated mice undergoing elastase perfusion was evaluated on Percentage increase in aortic diameter on day 14 after elastase perfusion (p=<0.001). Cobra venom factor-mediated complement depletion reduced mean aortic diameter expansion on day 14 to 90±4% compared with 156±2% in control mice (P<0.001) in experimental abdominal aortic aneurysm.
Synapse has enriched 10 related papers. Consider them for comparative context: